HK1210176A1 - Crystal form of chidamide, preparation method and use thereof - Google Patents
Crystal form of chidamide, preparation method and use thereofInfo
- Publication number
- HK1210176A1 HK1210176A1 HK15111090.9A HK15111090A HK1210176A1 HK 1210176 A1 HK1210176 A1 HK 1210176A1 HK 15111090 A HK15111090 A HK 15111090A HK 1210176 A1 HK1210176 A1 HK 1210176A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- chidamide
- preparation
- crystal form
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210489178.8A CN103833626B (zh) | 2012-11-27 | 2012-11-27 | 西达本胺的晶型及其制备方法与应用 |
| PCT/CN2012/086841 WO2014082354A1 (zh) | 2012-11-27 | 2012-12-18 | 西达本胺的晶型及其制备方法与应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1210176A1 true HK1210176A1 (en) | 2016-04-15 |
Family
ID=50797567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15111090.9A HK1210176A1 (en) | 2012-11-27 | 2015-11-11 | Crystal form of chidamide, preparation method and use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9573901B2 (hu) |
| EP (1) | EP2930169B1 (hu) |
| JP (1) | JP6387011B2 (hu) |
| KR (1) | KR20150082490A (hu) |
| CN (1) | CN103833626B (hu) |
| AU (1) | AU2012395573C1 (hu) |
| BR (1) | BR112015011898B1 (hu) |
| CA (1) | CA2891006C (hu) |
| DK (1) | DK2930169T3 (hu) |
| ES (1) | ES2691395T3 (hu) |
| HK (1) | HK1210176A1 (hu) |
| HR (1) | HRP20181704T1 (hu) |
| HU (1) | HUE040649T2 (hu) |
| PL (1) | PL2930169T3 (hu) |
| PT (1) | PT2930169T (hu) |
| RS (1) | RS57856B1 (hu) |
| RU (1) | RU2603138C1 (hu) |
| SI (1) | SI2930169T1 (hu) |
| WO (1) | WO2014082354A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| CN107868044B (zh) * | 2016-09-27 | 2020-10-16 | 深圳微芯生物科技股份有限公司 | 一种非溶剂化晶体及其制备方法与应用 |
| CN109985039A (zh) * | 2017-12-29 | 2019-07-09 | 深圳微芯生物科技股份有限公司 | 用于治疗白血病的联合用药物及其在制备用于治疗急性髓性白血病的药物中的用途 |
| EP3884944A4 (en) * | 2018-11-20 | 2022-08-31 | Shenzhen Chipscreen Biosciences Co., Ltd. | USE OF CHIDAMID |
| CN112294810B (zh) * | 2019-07-29 | 2024-03-01 | 深圳微芯生物科技股份有限公司 | 含有西达本胺和表面活性剂的药物组合物 |
| US11878009B2 (en) * | 2019-09-10 | 2024-01-23 | Great Novel Therapeutics Biotech & Medicals Corporation | Anticancer combination of chidamide and celecoxib salts |
| EP4028002A4 (en) * | 2019-09-11 | 2023-06-14 | GNT Biotech & Medicals Corporation | ANTI-CANCER COMBINATION OF CHIDAMID AND CELECOXIB |
| CN117597124A (zh) * | 2021-07-08 | 2024-02-23 | 深圳微芯生物科技股份有限公司 | 西奥罗尼及其联合用药治疗乳腺癌的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244751B2 (en) * | 2003-02-14 | 2007-07-17 | Shenzhen Chipscreen Biosciences Ltd. | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| CN1284772C (zh) * | 2003-07-04 | 2006-11-15 | 深圳微芯生物科技有限责任公司 | 具有分化和抗增殖活性的苯甲酰胺类组蛋白去乙酰化酶抑制剂及其药用制剂 |
-
2012
- 2012-11-27 CN CN201210489178.8A patent/CN103833626B/zh active Active
- 2012-12-18 WO PCT/CN2012/086841 patent/WO2014082354A1/zh active Application Filing
- 2012-12-18 DK DK12889061.3T patent/DK2930169T3/en active
- 2012-12-18 JP JP2015543237A patent/JP6387011B2/ja active Active
- 2012-12-18 ES ES12889061.3T patent/ES2691395T3/es active Active
- 2012-12-18 KR KR1020157014782A patent/KR20150082490A/ko not_active Application Discontinuation
- 2012-12-18 PT PT12889061T patent/PT2930169T/pt unknown
- 2012-12-18 RS RS20181175A patent/RS57856B1/sr unknown
- 2012-12-18 HU HUE12889061A patent/HUE040649T2/hu unknown
- 2012-12-18 SI SI201231417T patent/SI2930169T1/sl unknown
- 2012-12-18 EP EP12889061.3A patent/EP2930169B1/en active Active
- 2012-12-18 RU RU2015123682/04A patent/RU2603138C1/ru active
- 2012-12-18 PL PL12889061T patent/PL2930169T3/pl unknown
- 2012-12-18 BR BR112015011898-4A patent/BR112015011898B1/pt active IP Right Grant
- 2012-12-18 US US14/646,371 patent/US9573901B2/en active Active
- 2012-12-18 AU AU2012395573A patent/AU2012395573C1/en active Active
- 2012-12-18 CA CA2891006A patent/CA2891006C/en active Active
-
2015
- 2015-11-11 HK HK15111090.9A patent/HK1210176A1/xx unknown
-
2018
- 2018-10-18 HR HRP20181704TT patent/HRP20181704T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2930169T1 (sl) | 2018-11-30 |
| US20150299126A1 (en) | 2015-10-22 |
| CA2891006A1 (en) | 2014-06-05 |
| AU2012395573B2 (en) | 2016-11-17 |
| PT2930169T (pt) | 2018-10-30 |
| PL2930169T3 (pl) | 2018-12-31 |
| CN103833626B (zh) | 2015-11-25 |
| CN103833626A (zh) | 2014-06-04 |
| ES2691395T3 (es) | 2018-11-27 |
| AU2012395573C1 (en) | 2017-10-05 |
| JP6387011B2 (ja) | 2018-09-05 |
| WO2014082354A1 (zh) | 2014-06-05 |
| HUE040649T2 (hu) | 2019-03-28 |
| RU2603138C1 (ru) | 2016-11-20 |
| JP2016500081A (ja) | 2016-01-07 |
| US9573901B2 (en) | 2017-02-21 |
| KR20150082490A (ko) | 2015-07-15 |
| RS57856B1 (sr) | 2018-12-31 |
| HRP20181704T1 (hr) | 2018-12-28 |
| EP2930169B1 (en) | 2018-07-18 |
| EP2930169A4 (en) | 2016-06-08 |
| BR112015011898B1 (pt) | 2021-11-16 |
| AU2012395573A1 (en) | 2015-06-25 |
| CA2891006C (en) | 2017-06-06 |
| EP2930169A1 (en) | 2015-10-14 |
| DK2930169T3 (en) | 2018-11-12 |
| BR112015011898A2 (pt) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208439A1 (en) | 5-azaindazole compounds and methods of use 5- | |
| ZA201501858B (en) | Anti-mcam antibodies and associated methods of use | |
| HRP20181704T1 (hr) | Kristalni oblik kidamida, metoda pripreme i uporabe istog | |
| PT2925782T (pt) | Anticorpos anti-cd47 e métodos de utilização destes | |
| EP2912178A4 (en) | SUPER AMPLIFIER AND METHOD FOR USE THEREOF | |
| EP2895083A4 (en) | LIGATOR AND METHOD FOR ITS USE | |
| EP2808318A4 (en) | CRYSTALLINE FORM OF PROSTAGLANDIN ANALOGUE, PROCESS FOR PREPARING SAME AND USE THEREOF | |
| EP2803657A4 (en) | CRYSTAL FORM OF PROSTAGLANDINANALOGA AND METHOD OF PREPARING THEREOF AND USE THEREOF | |
| IL238227A0 (en) | Antibodies against c16orf54 and uses thereof | |
| EP2835369A4 (en) | CRYSTALLIZED SHAPE OF CABAZITAXEL AND METHOD FOR PRODUCING THE SAME | |
| ZA201404675B (en) | Anti-lrp5 antibodies and methods of use | |
| EP2938632A4 (en) | ANTI-GRANULYSIN ANTIBODIES AND METHODS OF USE | |
| EP2718331A4 (en) | N, N, N-TRIALKYL POLYMERS, METHODS FOR THEIR PREPARATION, AND USES THEREOF | |
| EP2731429A4 (en) | COMPOUNDS, METHODS OF PREPARATION AND METHODS OF USE | |
| HK1209432A1 (en) | Anti-jagged antibodies and methods of use | |
| EP2759529A4 (en) | PROCESS FOR PREPARING 1-PALMITOYL-3-ACETYLGLYCEROL AND PROCESS FOR PREPARING 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL THEREWITH | |
| EP2813495A4 (en) | 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF | |
| ZA201504167B (en) | Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates | |
| EP2837624A4 (en) | 4-SUBSTITUTE-2-HYDROXYLMORPHOLIN-3-ON AND METHOD OF MANUFACTURING THEREOF | |
| EP2844219A4 (en) | SENSITIZING COMPOSITION AND METHOD OF USE | |
| HK1216891A1 (zh) | 苔蘚素組合物、其製備方法和用途 | |
| IL234492A (en) | Crystalline forms of 5α - androstane - 3 β, 56β, - triol and methods for their preparation | |
| EP2870133A4 (en) | TETRAHYDRO ISOHUMULOD DERIVATIVES, METHOD FOR THE PREPARATION AND USE THEREOF | |
| EP2924021A4 (en) | ANTI-HIV COMPOUND AND MANUFACTURING METHOD AND USE THEREOF | |
| IL238934A0 (en) | Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use |